Return on Investment (ROI) calculations describe the economic value of an intervention or project by organizing the projected costs and benefits. In healthcare, this economic value is often used to determine what gets approved in the budget, what gets funded and which purchases are made. Understanding the business logic of quantifying time and risk in order to make budget priorities can lead to successfully funded proposals. The need to focus on inpatient glycemic management is often driven by the sheer volume of patients that will experience persistent hyperglycemia during their inpatient stay. This offers a compelling argument for workload, but not the data needed to demonstrate economic value. Data can and should drive decisions about how glycemic management is provided in your organization. Return on investment is a strategy that pulls together the known value of various outcomes measures in order to evaluate the cost of risk mitigation for both hyperglycemia and hypoglycemia.

Presented at AADE19

Authors: Cathy Jaynes PhD RN, Clinical Specialist